A carregar...
Treatment of ErbB2 breast cancer by mitochondrial targeting
BACKGROUND: ErbB2 breast cancer still remains an unmet need due to primary and/or acquired resistance to current treatment strategies. MEDICA compounds consist of synthetic long-chain α,ω-dicarboxylic acids previously reported to suppress breast cancer in PyMT transgenic mice. METHODS: MEDICA effica...
Na minha lista:
| Publicado no: | Cancer Metab |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362624/ https://ncbi.nlm.nih.gov/pubmed/32695336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-020-00223-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|